Ryman Healthcare Limited Stock Cash And Equivalents
RH7 Stock | EUR 2.49 0.01 0.40% |
Ryman Healthcare Limited fundamentals help investors to digest information that contributes to Ryman Healthcare's financial success or failures. It also enables traders to predict the movement of Ryman Stock. The fundamental analysis module provides a way to measure Ryman Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ryman Healthcare stock.
Ryman |
Ryman Healthcare Limited Company Cash And Equivalents Analysis
Ryman Healthcare's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
Competition |
In accordance with the recently published financial statements, Ryman Healthcare Limited has 0.0 in Cash And Equivalents. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Long-Term Care Facilities industry. The cash and equivalents for all Germany stocks is 100.0% higher than that of the company.
Ryman Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ryman Healthcare's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ryman Healthcare could also be used in its relative valuation, which is a method of valuing Ryman Healthcare by comparing valuation metrics of similar companies.Ryman Healthcare is currently under evaluation in cash and equivalents category among its peers.
Ryman Fundamentals
Return On Equity | 0.18 | |||
Return On Asset | -7.0E-4 | |||
Profit Margin | 1.13 % | |||
Operating Margin | (0.02) % | |||
Current Valuation | 3.82 B | |||
Shares Outstanding | 530.46 M | |||
Shares Owned By Insiders | 11.54 % | |||
Shares Owned By Institutions | 16.69 % | |||
Price To Earning | 15.33 X | |||
Price To Book | 0.93 X | |||
Price To Sales | 3.46 X | |||
Revenue | 503.76 M | |||
Gross Profit | 42.52 M | |||
EBITDA | 788.44 M | |||
Net Income | 692.87 M | |||
Total Debt | 2.58 B | |||
Debt To Equity | 61.60 % | |||
Current Ratio | 0.64 X | |||
Book Value Per Share | 7.26 X | |||
Cash Flow From Operations | 585.98 M | |||
Earnings Per Share | 0.66 X | |||
Price To Earnings To Growth | 2.57 X | |||
Number Of Employees | 6.8 K | |||
Beta | 0.79 | |||
Market Capitalization | 1.99 B | |||
Total Asset | 10.97 B | |||
Annual Yield | 0.04 % | |||
Net Asset | 10.97 B | |||
Last Dividend Paid | 0.22 |
About Ryman Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ryman Healthcare Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ryman Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ryman Healthcare Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Ryman Stock
Ryman Healthcare financial ratios help investors to determine whether Ryman Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ryman with respect to the benefits of owning Ryman Healthcare security.